Amgen is a pioneer in the science of using living cells to make biologic medicines.

Feature The Digital Cell Biology Revolution A new nanofluidic technology that uses light to manipulate cells is already changing how biotech research is done. Invented by Berkeley Lights and developed with early input from Amgen, the technology has immediate applications and abundant long-term potential.
Feature The Hunt for New Checkpoint Inhibitors Feature 10 Things to Know About Lipoprotein(a) Feature A Strategy for Making Clinical Trials More Successful Feature Amgen's First-in-Class Science Feature The New Genetics: Inside Amgen's Human Genome Experiment Feature How Real-World Data is Transforming Drug Development Feature Protein Engineering: Unlocking the Power of Proteins Feature The Passionate Pursuit of Nav 1.7

The Shape of Drugs to Come

Biotechnology opened the door to new types of medicines based on nature’s own building blocks. No company has done more to advance this revolution than Amgen, and the company’s broad toolkit of drug modalities just got larger.

Feature Better Science Through Biosimilar R&D Feature The Next Generation of Biotech Manufacturing Feature Amgen’s Growing Immunotherapy Arsenal

Subscribe for the latest from Amgen Science.

System error message. Lorem ipsum.
I authorize Amgen and its contractors to use my email address and provide me with updates, informational material, and/or contact me about Amgen Science. I understand that my email address will not be used for any other purposes. I understand that receiving these communications is optional and free and that I have the ability to opt out at anytime. For more information, please see the Amgen privacy policy.